Skip to main content

Table 1 Single factor analysis of VTE risk warning indicators in modeling dataset

From: Predicting the occurrence of venous thromboembolism: construction and verification of risk warning model

Variables

No.

 

VTE group

Control group

χ2or t

P

n(%)or−X ± S

n(%)or−X ± S

Gender

X1

Male

109 (42.4)

123 (47.9)

1.540

0.215

Female

148 (57.6)

134 (52.1)

Patient source

X2

City

142 (55.3)

162 (63.0)

3.221

0.073

Countryside

115 (44.7)

95 (37.0)

Native place

X3

Native

249 (96.9)

253 (98.4)

1.365

0.243

Non-native

8 (3.1)

4 (1.6)

Payment method

X4

Health Insurance

111 (43.2)

138 (53.7)

5.679

0.017*

Self-paying

146 (56.8)

119 (46.3)

Length of stay (days)

X5

 

13.28 ± 6.64

13.00 ± 19.96

−2.998

0.003*

Cough

X6

No

218 (84.8)

197 (76.7)

5.517

0.019*

Yes

39 (15.2)

60 (23.3)

Expectorant

X7

No

227 (88.3)

246 (95.7)

9.568

0.002*

Yes

30 (11.7)

11 (4.3)

Hemoptysis

X8

No

244 (94.9)

251 (97.7)

2.678

0.102

Yes

13 (5.1)

6 (2.3)

Difficulty breathing

X9

No

250 (97.3)

253 (98.4)

0.836

0.361

Yes

7 (2.7)

4 (1.6)

Pleural chest pain

X10

No

230 (89.5)

251 (97.7)

14.28

<0.001*

Yes

27 (10.5)

6 (2.3)

Cyanosis

X11

No

244 (94.9)

254 (98.8)

6.451

0.011*

Yes

13 (5.1)

3 (1.2)

Anterior cardiac pain

X12

No

250 (97.3)

255 (99.2)

1.809

0.176

Yes

7 (2.7)

2 (0.8)

Palpitations

X13

No

251 (97.7)

252 (98.1)

0.093

0.761

Yes

6 (2.3)

5 (1.9)

Shortness of breath after exertion

X14

No

245 (95.3)

252 (98.1)

2.981

0.084

Yes

12 (4.7)

5 (1.9)

Chest tightness and shortness of breath

X15

No

184 (71.6)

244 (94.9)

50.272

<0.001*

Yes

73 (28.4)

13 (5.1)

Unexplained syncope

X16

No

238 (92.6)

254 (98.8)

12.157

<0.001*

Yes

19 (7.4)

3 (1.2)

Pleural effusion

X17

No

241 (93.8)

247 (96.1)

1.458

0.227

Yes

16 (6.2)

10 (3.9)

Unilateral lower limb pain

X18

No

201 (78.2)

255 (99.2)

56.671

<0.001*

Yes

56 (21.8)

2 (0.8)

Deep vein tenderness in lower limbs

X19

No

253 (98.4)

256 (99.6)

0.808

0.369

Yes

4 (1.6)

1 (0.4)

Lower extremity pigmentation

X20

No

255 (99.2)

257 (100)

0.502

0.479

Yes

2 (0.8)

0 (0)

Lower limb walking fatigue

X21

No

256 (99.6)

254 (98.8)

0.252

0.616

Yes

1 (0.4)

3 (1.2)

Local lower skin temperature increase

X22

No

252 (98.1)

256 (99.6)

1.518

0.218

Yes

5 (1.9)

1 (0.4)

Hypertension

X23

No

169 (65.8)

197 (76.7)

7.439

0.006*

Yes

88 (34.2)

60 (23.3)

Diabetes

X24

No

231 (89.9)

240 (93.4)

2.056

0.152

Yes

26 (10.1)

17 (6.6)

Smoking

X25

No

200 (77.8)

217 (84.4)

3.672

0.055

Yes

57 (22.2)

40 (15.6)

Systemic connective tissue disease

X26

No

255 (99.2)

252 (98.1)

0.579

0.447

Yes

2 (0.8)

5 (1.9)

Renal insufficiency

X27

No

248 (96.5)

254 (98.8)

3.072

0.08

Yes

9 (3.5)

3 (1.2)

Liver disease

X28

No

234 (91.1)

220 (85.6)

2.641

0.104

Yes

23 (8.9)

37 (14.4)

anemia

X29

No

246 (95.7)

250 (97.3)

0.921

0.337

Yes

11 (4.3)

7 (2.7)

PT (s)

X30

 

12.95 ± 7.29

12.66 ± 7.73

0.438

0.662

TT(s)

X31

 

18.28 ± 3.75

17.72 ± 1.58

2.206

0.028*

APTT(s)

X32

 

29.47 ± 6.76

30.20 ± 5.94

−1.300

0.194

FIB(g/L)

X33

 

2.84 ± 0.84

2.83 ± 0.89

0.131

0.896

FDP

X34

 

23.16 ± 28.85

5.28 ± 5.78

9.742

<0.001*

INR

X35

 

1.15 ± 1.23

1.09 ± 0.81

0.653

0.514

D-Dimer (mg/L)

X36

 

8.55 ± 14.37

1.37 ± 2.14

7.923

<0.001*

albumin (g/L)

X37

 

36.88 ± 5.05

37.01 ± 5.10

−0.290

0.772

Platelet (*109/L)

X38

 

193.57 ± 74.38

188.94 ± 81.93

0.671

0.503

WBC(*109/L)

X39

 

7.44 ± 2.81

6.42 ± 3.27

3.793

<0.001*

RBC(*109/L)

X40

 

4.43 ± 3.66

4.23 ± 0.64

0.863

0.389

Caprini score

X41

 

4.60 ± 2.72

3.56 ± 1.13

5.661

<0.001*

  1. *Note: *Statistically significant at 0.05 leve